Associated Papers
Mice with reduced protease-activated receptor 4 reactivity show decreased venous thrombosis and platelet procoagulant activity.
Knauss EA et al.
Journal of Thrombosis and Haemostasis : Jth, 2025
Mice with Reduced PAR4 Reactivity show Decreased Venous Thrombosis and Platelet Procoagulant Activity.
Knauss EA et al.
Biorxiv : the Preprint Server for Biology, 2024
A mouse model of the protease-activated receptor 4 Pro310Leu variant has reduced platelet reactivity.
Han X et al.
Journal of Thrombosis and Haemostasis : Jth, 2024
Osteomesopyknosis associated with a novel ALOX5 variant that impacts the RANKL pathway.
Fernandez-Luna JL et al.
Molecular Genetics & Genomic Medicine, 2024
38803233 (PubMed )
Supplement: MGG3-12-e2471-s001.xls › Sheet1
A Mouse Model of the Protease Activated Receptor 4 (PAR4) Pro310Leu Variant has Reduced Platelet Reactivity.
Han X et al.
Biorxiv : the Preprint Server for Biology, 2023
PAR4 activation involves extracellular loop 3 and transmembrane residue Thr153.
Han X et al.
Blood, 2020
Select a paper to view details